MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
基本信息
- 批准号:6105233
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Specialized mass spectrometric analyses are
provided to the institute and to other collaborating units. The
emphasis is split between the identification of biologically active
trace organic compounds isolated from natural sources and the
mass spectrometry of biopolymers (e.g. peptide, proteins and
oligonucleotides). A very close working relationship and
collaboration is maintained with the Laboratory of Biophysical
Chemistry, NHLBI. While this group runs many routine analyses
for laboratories at NIH, as much emphasis as possible is placed on
research using mass spectrometry for the structural elucidation of
biologically active compounds. Key projects include: the structural
identification of potent anti-HIV and anti-cancer compounds; the
identification of post-translational modifications in proteins;
continued research on cyanovirin, a potent anti-HIV compound
heading towards clinical trial; development of techniques for micro-
scale LCMS of biopolymers with the aim of greatly enhancing
sensitivity; the identification of Perilipin C which mediates lipid
metabolism; an examination of sialic acid in relation to malaria
transmission by mosquitos; the identification and chiral
determination of abnormal and modified amino acids as found in
marine natural products; the identification of modified hemoglobins
formed during treatments for sickle cell anaemia; sequence
corrections to the hemoglobin alpha- and beta-chains of the rhesus
monkey used in sickle cell research; and the development of
methods for phospholipid identification. The addition of a new
HP-LCMS instrument late last year has drastically expanded the
abilities and productivity of the group. A collaboration continues
with The National Institute of Standards and Technology (NIST)
involving the measurement of mass spectra of organic compounds
from NIH, the Walter Reed Army Institute of Research and other
government agencies. These are then put into the NIST/EPA/NIH
mass spectral database which is in use world wide.
专业的质谱分析是
提供给研究所和其他合作单位。这个
重点是对生物活性的鉴定
从天然来源中分离的痕量有机化合物和
生物聚合物的质谱学(例如,肽、蛋白质和
寡核苷酸)。非常密切的工作关系和
与生物物理实验室保持合作
化学,NHLBI。虽然该小组进行了许多例行分析
对于NIH的实验室,尽可能多地强调
利用质谱学进行结构鉴定的研究
具有生物活性的化合物。重点项目包括:结构
鉴定有效的抗艾滋病毒和抗癌化合物;
蛋白质翻译后修饰的鉴定;
一种有效的抗HIV化合物--氰韦林的继续研究
走向临床试验;微创技术的发展
生物聚合物的规模化LC MS,目的是大大提高
调脂药物Perilipin C的敏感性鉴定
新陈代谢;与疟疾有关的唾液酸检查
蚊子传播;鉴定和手性
中发现的异常和修饰氨基酸的测定
海洋天然产品.改性血红蛋白的鉴定
在治疗镰状细胞性贫血过程中形成的;序列
恒河猴血红蛋白α链和β链的改正
猴子在镰状细胞研究中的应用;以及
磷脂的鉴定方法。添加了一个新的
HP-LCMS仪器在去年年底大幅扩展了
团队的能力和生产力。协作仍在继续
与美国国家标准与技术研究所(NIST)
涉及有机化合物的质谱学测量
来自美国国立卫生研究院、沃尔特里德陆军研究所和其他机构
政府机构。然后将这些放入NIST/EPA/NIH
世界上正在使用的质谱学数据库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lewis K. Pannell其他文献
Cobalt(II) complexes of the 2-aminopicolineN-oxides and 2-amino-4, 6-lutidineN-oxide
- DOI:
10.1007/bf01041498 - 发表时间:
1988-02-01 - 期刊:
- 影响因子:1.700
- 作者:
Douglas X. West;John C. Severns;Lewis K. Pannell - 通讯作者:
Lewis K. Pannell
A new class of alkaloids from a dendrobatid poison frog: a structure for alkaloid 251F.
来自 dendrobatid 毒蛙的一类新生物碱:生物碱 251F 的结构。
- DOI:
10.1021/np50084a002 - 发表时间:
1992 - 期刊:
- 影响因子:5.1
- 作者:
T. Spande;H. Garraffo;H. Yeh;Q.;Lewis K. Pannell;John W. Daly - 通讯作者:
John W. Daly
Rectal Effluent as a Research Tool
- DOI:
10.1007/s10620-014-3330-0 - 发表时间:
2014-09-02 - 期刊:
- 影响因子:2.500
- 作者:
Jana M. Rocker;Jack A. DiPalma;Lewis K. Pannell - 通讯作者:
Lewis K. Pannell
Primary structure of a novel neuropeptide isolated from the corpora cardiaca of periodical cicadas having adipokinetic and hypertrehalosemic activities.
从具有脂肪运动和高海藻糖活性的周期蝉贲门体中分离出的新型神经肽的一级结构。
- DOI:
- 发表时间:
1995 - 期刊:
- 影响因子:3.8
- 作者:
Ashok K. Raina;Lewis K. Pannell;Jan Kochansky;Howard Jaffe - 通讯作者:
Howard Jaffe
Transition metal complexes of 3-acetylisoquinoline thiosemicarbazones as potential antifungal agents
- DOI:
10.1007/bf02910711 - 发表时间:
1992-10-01 - 期刊:
- 影响因子:1.700
- 作者:
John P. Scovill;Michael W. Blaney;Douglas X. West;Anthony E. Liberta;Lewis K. Pannell - 通讯作者:
Lewis K. Pannell
Lewis K. Pannell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lewis K. Pannell', 18)}}的其他基金
A Novel Approach for the Routine Screening for Ovarian Cancer
卵巢癌常规筛查的新方法
- 批准号:
8551644 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Profiling Urine Glycosylation of PSA and other Glyco-Biomarkers in Prostate Cance
分析前列腺癌中 PSA 和其他糖生物标志物的尿液糖基化
- 批准号:
7386271 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Profiling Urine Glycosylation of PSA and other Glyco-Biomarkers in Prostate Cance
前列腺癌中 PSA 和其他糖生物标志物的尿液糖基化分析
- 批准号:
7576898 - 财政年份:2008
- 资助金额:
-- - 项目类别:
MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
- 批准号:
6289766 - 财政年份:
- 资助金额:
-- - 项目类别:
Mass Spectrometry Of Drugs, Natural Products, Proteins,
药物、天然产物、蛋白质的质谱分析,
- 批准号:
6507291 - 财政年份:
- 资助金额:
-- - 项目类别:
MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
- 批准号:
6432107 - 财政年份:
- 资助金额:
-- - 项目类别:
Mass Spectrometry Of Drugs, Natural Products, Proteins,
药物、天然产物、蛋白质的质谱分析,
- 批准号:
6673454 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
-- - 项目类别:














{{item.name}}会员




